Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

331.00
Delayed Data
As of Aug 04
 -3.92 / -1.17%
Today’s Change
201.91
Today|||52-Week Range
340.34
+28.59%
Year-to-Date
Will Allergan's (AGN) Earnings Streak Continue in 2Q? - Analyst Blog
Aug 04 / Zacks.com
Allergan (AGN) in Focus: Stock Jumps 6.1% - Tale of the Tape
Jul 28 / Zacks.com
Shire Pharmaceuticals eyes the big league with Baxalta bid
Aug 04 / FT.com
Health Care & Industrials: Two ETFs Trading with Outsized Volume - ETF News And Comme...
Jul 28 / Zacks.com
Drugs Stocks On The Rise With Help From 3 Stocks
Aug 03 / TheStreet.com
Allergan signals appetite for new mega deal after $41bn disposal
Jul 27 / FT.com
Dan Loeb's Favorite Stock Picks
Aug 03 / Benzinga
Pharma M&A: portfolio theory
Jul 27 / FT.com
Futures Open Mixed; Obama Pushes Emissions Reductions
Aug 02 / TheStreet.com
Weak sales outlook hits machinery makers
Jul 27 / FT.com
The Most Important Number in Gilead Sciences' Earnings Report
Aug 02 / MotleyFool.com
Teva Pharmaceutical to Buy Allergan's Generics Unit in $40.5 Billion Deal - Stocks in...
Jul 27 / Zacks.com
Car Sales, Jobs Report, Earnings Are Highlights This Week
Aug 02 / TheStreet.com
Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
Jul 27 / MotleyFool.com
Allergan is Cramer's Favorite Stock, Teva Deal Was 'Incredible'
Aug 01 / TheStreet.com
Mylan share price plunges after Teva abandons bid
Jul 27 / FT.com
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
Jul 31 / TheStreet.com
China Tanks as Q2 Marches On - Ahead of Wall Street
Jul 27 / Zacks.com
Top 10 News for 7/27 - 7/31: Teva Makes it Official with Allergan; China Stock Slide ...
Jul 31 / Investing Channel
Teva buys Allergan's generic drugs business for $40.5 billion
Jul 27 / CNNMoney.com
Dr. Reddy's Q1 Earnings & Revenues Rise Y/Y, Offers View - Analyst Blog
Jul 31 / Zacks.com
Allergan sells generic drugs unit to Teva for $40bn
Jul 27 / FT.com
Israel ETFs Surge on Teva Megamerger Deal (revised) - ETF News And Commentary
Jul 31 / Zacks.com
Stocks: 5 things to know before the open
Jul 27 / CNNMoney.com
Teva's Q2 Earnings & Revenues Beat Expectations, View Up - Analyst Blog
Jul 31 / Zacks.com
Shire's (SHPG) Q2 Earnings Lag Estimates, 2015 View Raised - Analyst Blog
Jul 24 / Zacks.com
Analysts' Actions -- Amazon, Caterpillar and Yelp
Jul 29 / TheStreet.com
Zacks Industry Outlook Highlights: AbbVie, Allergan, Pfizer, Juno and Johnson & Johns...
Jul 22 / Zacks.com
Teva to Buy Allergan's Generics Business for $40.5B - Analyst Blog
Jul 28 / Zacks.com
US health insurers rush to consolidate after Obamacare ruling
Jul 08 / FT.com
Pfizer CEO has 'sufficient courage' to pursue deals
Jul 28 / FT.com
Teva prepares to raise its bid for Mylan
Jul 06 / FT.com
Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Jul 28 / Zacks.com